Skip to content Skip to navigation

Bipolar Disorder

Repligen Corporation
Repligen Corporation
41 Seyon Street Building #1, Suite 100 Waltham, MA 02453 USA

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. A number of drug development programs are currently being conducted to evaluate our drug candidates in diseases such as bipolar disorder and Friedreich's ataxia.

Alkermes Inc
Alkermes Inc
852 Winter Street Waltham, MA 02451 USA

Alkermes focuses on therapies for widespread, chronic diseases, such as central nervous system disorders, addiction, diabetes and autoimmune disorders, where we feel we have the opportunity to make the greatest impact.